Academy Capital Management Inc Provectus Biopharmaceuticals, Inc. Transaction History
Academy Capital Management Inc
- $553 Million
- Q2 2024
A detailed history of Academy Capital Management Inc transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Academy Capital Management Inc holds 20,000 shares of PVCT stock, worth $2,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$2,200
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PVCT
# of Institutions
7Shares Held
229KCall Options Held
0Put Options Held
0-
Home Federal Bank Of Tennessee100KShares$11,0000.0% of portfolio
-
Lee Danner & Bass Inc50KShares$5,5000.0% of portfolio
-
Atlas Wealth LLC Cincinnati, OH26.6KShares$2,9280.0% of portfolio
-
Lbmc Investment Advisors, LLC22KShares$2,4200.0% of portfolio
-
Financial Symmetry Inc Raleigh, NC10.2KShares$1,1210.0% of portfolio
About PROVECTUS BIOPHARMACEUTICALS, INC.
- Ticker PVCT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 419,496,992
- Market Cap $46.1M
- Description
- Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...